A new use for okra? Researchers seek natural, alternative method to treat diabetes

Abelmoschus esculentus (AE) is one the natural plant that has been used to manage diabetes. Credit: CC Natalie Maynor http://www.flickr.com/photos/nataliemaynor/7163983339/

Researchers have studied the suitability of Abelmoschus Esculentus (AE) as complementary or as an alternative approach to treat diabetics.

Numerous studies have been carried out on AE but not much report is available on the bioactive properties of AE despite its wide usage as a medicinal plant. This study attempts to find out the hypoclycemic effects of AE, known as Okra (lady's finger),a in the mallow family and is cultivated in tropical and warm temperate regions around the world.

The researchers investigated differential expression of diabetic-specific genes in liver tissues of streptozotocin (STZ)-induced in response to AE treatment. Induced mice were divided into two groups (i) mice (n=4) were given distilled water and were set as a control, and ii) mice (n=4) were treated with 250 mg/kg of AE.

Three diabetes-specific genes of interest; carboxylesterase 2 (CES2), stearoyl-Coenzyme A desaturase 1 (SCD1) and insulin-like growth factor 1(IGF1) were selected and the of these genes were examined quantitatively. The results showed SCD1 and IGF1 were upregulated at 3.94 and 1.17 fold respectively and CES2 was downregulated at – 1.92.

This molecular study revealed the anti-diabetic properties of the AE and suggests that the extract could be developed as a prospective phytomedicinal plant. However, the researchers indicated that the physiological status of each rat may give different results with different interpretation.

The researchers suggest that future studies should involve larger array of genes analysis system, for example using microarray as a tool to reveal the of the hypoglycemic properties of AE.

The findings in this experiment revealed the changes in that may relate to the underlying mechanism of diabetic pathophysiology, suggesting a new potential target for . Knowledge gained from this may be used to develop a new research which could enable researchers to extract the pure compound that actually demonstrated the hypoglycemic effect in diabetic mice.

add to favorites email to friend print save as pdf

Related Stories

Type 1 diabetes may result from good genes behaving badly

Sep 19, 2008

New research from Stanford University scientists suggests that type 1 diabetes, an autoimmune disease that develops in children and young adults, may not be due to bad genes but rather to good genes behaving badly.

Research aims to prevent diabetic kidney failure

Nov 05, 2011

The enzyme arginase-2 plays a major role in kidney failure, and blocking the action of this enzyme might lead to protection against renal disease in diabetes, according to researchers.

Recommended for you

Blood glucose levels set for achieving HbA1c targets

Apr 11, 2014

(HealthDay)—The average self-monitored blood glucose (SMBG) concentrations needed at premeal, postmeal, and bedtime have been established to achieve a range of hemoglobin A1c (HbA1c) targets, according ...

Women with diabetes less likely to have a mammogram

Apr 11, 2014

Women with diabetes are 14 per cent less likely to be screened for breast cancer compared to women without diabetes, according to a study by researchers at the Institute for Clinical Evaluative Sciences (ICES) and Women's ...

Nonalcoholic fatty liver disease linked to CKD in T1DM

Apr 09, 2014

(HealthDay)—For patients with type 1 diabetes, nonalcoholic fatty liver disease (NAFLD) is independently associated with the risk of incident chronic kidney disease (CKD), according to a study published ...

Common diabetes treatment could extend hypoglycaemia

Apr 08, 2014

(Medical Xpress)—Researchers at the University of Adelaide have discovered that a common treatment for people with type 2 diabetes could cause longer-than-normal periods of the low blood sugar reaction hypoglycaemia, which ...

User comments